臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52848731 在线人数 : 680 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 746-755 / 1137 (共114页)
<< < 70 71 72 73 74 75 76 77 78 79 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2020-05-26T09:27:22Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang P.-C.;Pao W;Cheng A.-L;Bean J;Huang C.-L;Shun C.-T;Huang C.-J;Lin Z.-Z;Chen K.-Y;Tsai M.-C;Hu F.-C;Chang Y.-C;Shih J.-Y;Yu C.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Chang Y.-C; Hu F.-C; Tsai M.-C; Chen K.-Y; Lin Z.-Z; Huang C.-J; Shun C.-T; Huang C.-L; Bean J; Cheng A.-L; Pao W; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:18Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Yang P.-C.; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y; Chen J.-H; Chen K.-Y; Chen K.-Y;Chen J.-H;Shih J.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T.
臺大學術典藏	2020-05-26T09:27:18Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H;Yu C.-J;Chen K.-Y;Shih J.-Y;Lin Y.-L;Chih-Hsin Yang; Lee J.-H; Yu C.-J; Chen K.-Y; Shih J.-Y; Lin Y.-L; CHIH-HSIN YANG

显示项目 746-755 / 1137 (共114页)
<< < 70 71 72 73 74 75 76 77 78 79 > >>
每页显示[10|25|50]项目